Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eloria vs FuturHealth

Eloria
Graded #224

Lower grade

vs+0.19999999999998863
FuturHealth
Graded #219

Higher grade

The verdict

FuturHealth takes it — 65.6/100 to 65.4/100, but only just.

FuturHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added Eloria is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFuturHealth +12
48
60
Dose & formulationFuturHealth +5
76
81
Clinical oversightEloria +12
79
67
Labs & monitoringFuturHealth +9
52
61
FulfillmentEloria +19
81
62
Contract termsEloria +6
61
55
Eloria · left barFuturHealth · right bar

The numbers

MetricEloriaFuturHealth
WeighScore65.4/10065.6/100
GradeCC
Scorecard rank#224#219
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)$199/mo (compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Eloria

Graded #224 · C

Strengths

  • Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
  • Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
  • Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
  • HSA/FSA accepted, free shipping on every order, and 24/7 support
  • Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)

Where it loses points

  • Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
  • State availability varies and is not published - only where providers are licensed and pharmacies can dispense
  • The compounding pharmacy partner is not named (US-licensed pharmacies only)
  • No LegitScript certification displayed
  • Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model
FuturHealth

Graded #219 · C

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

Where it loses points

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard